Comparison of Clinical Characteristics Between Clinical Trial Participants and Nonparticipants Using Electronic Health Record Data

Authors:

Abstract
Clinical trials are considered one of the best study designs for generating medical evidence. A common challenge for individuals interpreting clinical trials is assessing generalizability, which is the practice of determining how reasonably relevant the results are to a particular group of individuals who were not part of the trial.1 A variety of these comparisons have shown disparities across many disease domains. In cancer trials, many studies2-5 have noted that trial participants tend to be younger, with more promising prognoses and fewer comorbidities. In cardiovascular (CV) disease trials, participants are more likely to be male, with less risk for developing CV outcomes.3,6 In a meta-analysis of end-stage kidney disease trials, participants were found to be younger and to have different comorbidity profiles.7 Other disease domains in which similar concerns are noted include mental health, psoriasis, and type 2 diabetes.3,8-10 Understanding differences between trial participants and nonparticipants is important because underlying characteristics can influence the estimated effect of an intervention, ultimately impacting its clinical meaningfulness.1 However, many of these prior assessments examined only aggregated estimates between trial participants and nonparticipants with comparisons based on tabular data reported by the selected trials, providing limited insight when comparing the 2 groups. A novel combination of prior trial enrollment data and electronic health records (EHRs) may provide more granular and detailed assessments by leveraging individual participants’ medical history. To our knowledge, prior literature reviews on use of EHR data and other similar data sources for generalizability purposes have found no study exploring this particular linkage.3,11,12

This publication has 38 references indexed in Scilit: